Bayer AG, one of the world’s largest and most successful manufacturers of pharmaceuticals, has finally begun to get an idea of just how much their failure to warn users of the dangers of one of their most popular drugs is going to cost them.
The company recently announced that settlements in the lawsuits involving its Yasmin line of birth control pills have now totaled $142 million. In total, Bayer has thus far settled 651 cases where users sued the company due to a failure to properly warn them about the risks of taking the once popular birth control drug. At an average of $218,000 per case, it has become painfully clear that Bayer’s irresponsibility is costing them dearly, and there appears to be little relief in sight any time soon.
In total, as of recent estimates, Bayer faces almost 12,000 lawsuits over Yaz and Yasmin, and some experts predict that the ultimate settlement figures are likely to end up in the billions. Yasmin was the fourth best selling oral contraceptive in the United States in 2011, but the company’s trouble centers around the fact that they were not nearly forthcoming enough in revealing that the drugs more than triple the risk of blood clots in their users.